PARIS: Air Liquide has acquired homecare entities in Belgium and the Netherlands, supporting 10,000 patients with chronic conditions. The €10 million turnover operation adds to the Group’s existing support of 2 million people worldwide and aligns with its focus on Home Healthcare as a priority development area.
The acquisition includes VitalAire, Air Liquide’s Home Healthcare brand, which is set to enhance its medico-technical expertise and digital service offerings in the region. This move promises to improve patient care plans through the combined geographic and therapeutic strengths of the new entities and the professionalism of Air Liquide’s teams.
Air Liquide Healthcare, a leader in medical gases and home healthcare services, employs 16,500 people to aid 2 million chronic patients and supply medical gases to 20,000 hospitals. The Group’s commitment to Value-based Healthcare aims to deliver patient benefits efficiently, contributing to a sustainable healthcare system.
Globally, Air Liquide stands as a leader in gases, technologies, and services for industry and healthcare, operating in 72 countries with 67,800 employees. Its strategic plan, ADVANCE 2025, focuses on global performance and sustainable solutions, including hydrogen for climate and energy transition. With a 2023 revenue of over €27.5 billion, Air Liquide is listed on the Euronext Paris and included in major indexes like CAC 40 and EURO STOXX 50.
Diana Schillag , member of Air Liquide’s Executive Committee in charge of Healthcare, Sustainable Development and Procurement, stated: “We are delighted to strengthen our position in those growing markets and to welcome these new patients and employees to Air Liquide. As a major player in Home Healthcare throughout the world, our ambition is to improve the quality of life of patients to best meet their needs at the lowest cost to society, thereby contributing to more efficient and sustainable healthcare systems.”
